SAN FRANCISCO, Aug. 27, 2015 /PRNewswire-USNewswire/ -- QB3@953—a San Francisco incubator created by QB3, a University of California (UC) research institute and biotech accelerator— today announced an agreement with pharmaceutical company GSK to identify and facilitate collaborations to translate early drug target concepts into medicines that benefit patients.